| Company Name: | Mentor Corporation Minnesota | | Ticker Symbol: | MNT | | | WWW Address: | www.mentorcorp.com | | CEO: | Joshua H. Levine | | No. of Employees: | 1,190 | | Common Issue Type: | CS | | Business Description: | The Company develops, manufactures, licenses and markets a range of products serving the aesthetic market, including plastic and reconstructive surgery.
|
| | | Industry Information: | HEALTH SERVICES - Medical Appliances & Equipment [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 31.01 |  0.0 | - | - | 0 | 31.01 | 30.99 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 1,048.1 | 33.8 | 1.57 | 1.60 | 0.80 | 20.8 | 2.6 | 35.92 - 13.33 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 31.01 | $ | | PE Ratio - LTM | 20.8 | |
| Market Capitalisation | 1,047.5 | mil |
| Latest Shares Outstanding | 33.8 | mil |
| Earnings pS (EPS) | 1.60 | $ |
| Dividend pS (DPS) | 0.80 | ¢ |
| Dividend Yield | 2.6 | % |
| Dividend Payout Ratio | 50 | % |
| Revenue per Employee | 313,620 | $ |
| Effective Tax Rate | 29.8 | % |
| Float | 33.2 | mil |
| Float as % of Shares Outstanding | 98.4 | % |
| Foreign Sales | 116 | mil |
| Domestic Sales | 257 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 42.30 | % |
| Research & Devlopment (R&D) as % of Revenue | 11.60 | % |
| Gross Profit Margin | 76.1 | % |
| EBITDA Margin | 22.2 | % |
| Pre-Tax Profit Margin | 17.2 | % |
| Assets Turnover | 0.9 | % |
| Return on Assets (ROA) | 12.7 | % |
| Return on Equity (ROE) | 37.6 | % |
| Return on Capital Invested (ROCI) | 18.7 | % |
| Current Ratio | 2.5 | |
| Leverage Ratio (Assets/Equity) | 3.0 | |
| Interest Cover | 12.8 | |
| Total Debt/Equity (Gearing Ratio) | 1.01 | |
| LT Debt/Total Capital | 50.0 | % |
| Working Capital pS | 5.01 | $ |
| Cash pS | 2.05 | $ |
| Book-Value pS | 4.43 | $ |
| Tangible Book-Value pS | 1.96 | $ |
| Cash Flow pS | 2.14 | $ |
| Free Cash Flow pS | 0.13 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 7.00 | |
| Price/Tangible Book Ratio | 15.82 | |
| Price/Cash Flow | 14.5 | |
| Price/Free Cash Flow | 238.5 | |
| P/E as % of Industry Group | 133.0 | % |
| P/E as % of Sector Segment | 118.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Cash Payment |
| Dividend Rate | 0.80 |
| Current Dividend Yield | 2.6 |
| 5-Y Average Dividend Yield | 1.9 |
| Payout Ratio | 50.0 |
| 5-Y Average Payout Ratio | 40.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.2 | 102 | 9,255 | 17,091 |
| 4 Weeks | 31.01 | 30.84 | 30.88 | 0.4 | 105 | 14,345 | 258,215 |
| 13 Weeks | 31.01 | 13.33 | 15.59 | 98.9 | 210 | 21,734 | 1,325,773 |
| 26 Weeks | 31.01 | 13.33 | 23.69 | 30.9 | 198 | 14,469 | 1,808,620 |
| 52 Weeks | 35.92 | 13.33 | 34.57 | -10.3 | 143 | 10,661 | 2,675,926 |
| YTD | 31.01 | 30.89 | - | 0.3 | 109 | 13,897 | 208,460 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 30.98 | 30.96 | 27.75 | 24.43 | 25.64 | 1.57 | 1.48 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -3.93 | 12.9 | 0.97 |
| Income | 15.47 | 19.2 | 6.73 |
| Dividend | 34.24 | 57.6 | 5.05 |
| Capital Spending | 0.00 | NA | 0.00 |
| R&D | 10.25 | NA | 13.08 |
| Normalized Inc. | 3.25 | NA | 2.58 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 5.0 | -1.1 | 23.6 |
| Earnings % | -22.5 | -1.1 | -78.2 |
| EPS % | -13.2 | 3.8 | -73.3 |
| EPS $ | -0.10 | 0.01 | -4.39 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 39.01 |
| Current Ratio | 2.5 |
| Quick Ratio (Acid Test) | 1.6 |
| Liquidity Ratio (Cash) | 0.93 |
| Receivables Turnover | 5.1 |
| Average Collection Period | 71 |
| Working Capital/Equity | 120.2 |
| Working Capital pS | 5.09 |
| Cash-Flow pS | 2.28 |
| Free Cash-Flow pS | -0.50 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 4.28 |
| Financial Leverage Ratio (Assets/Equity) | 3.1 |
| Debt Ratio | 67.5 |
| Total Debt/Equity (Gearing Ratio) | 1.07 |
| LT Debt/Equity | 1.06 |
| LT Debt/Capital Invested | 60.8 |
| LT Debt/Total Liabilities | 51.0 |
| Interest Cover | 14.7 |
| Interest/Capital Invested | 1.77 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 14.18 |
| Tobin's Q Ratio | 2.38 |
| Current P/E Ratio - LTM | 20.80 |
| Enterprise Value (EV)/EBITDA | 13.33 |
| Enterprise Value (EV)/Free Cash Flow | -78.47 |
| Dividend Yield | 2.6 |
| Price/Tangible Book Ratio - LTM | 15.82 |
| Price/Book Ratio - LTM | 7.00 |
| Price/Cash Flow Ratio | 14.5 |
| Price/Free Cash Flow Ratio - LTM | 238.5 |
| Price/Sales Ratio | 2.74 |
| P/E Ratio (1 month ago) - LTM | 20.7 |
| P/E Ratio (26 weeks ago) - LTM | 14.8 |
| P/E Ratio (52 weeks ago) - LTM | 22.2 |
| 5-Y High P/E Ratio | 43.9 |
| 5-Y Low P/E Ratio | 6.2 |
| 5-Y Average P/E Ratio | 22.5 |
| Current P/E Ratio as % of 5-Y Average P/E | 92 |
| P/E as % of Industry Group | 133.0 |
| P/E as % of Sector Segment | 118.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 23.7 |
| PER SHARE FIGURES |
| LT Debt pS | 4.49 |
| Current Liabilities pS | 3.51 |
| Tangible Book Value pS - LTM | 1.96 |
| Book Value pS - LTM | 4.43 |
| Capital Invested pS | 8.72 |
| Cash pS - LTM | 2.05 |
| Cash Flow pS - LTM | 2.14 |
| Free Cash Flow pS - LTM | 0.13 |
| Earnings pS (EPS) | 1.60 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -4.48 |
| Free Cash Flow Margin 5YEAR AVG | 33.67 |
| Net Profit Margin | 17.0 |
| Net Profit Margin - 5YEAR AVRG. | 28.5 |
| Equity Productivity | 2.61 |
| Return on Equity (ROE) | 44.3 |
| Return on Equity (ROE) - 5YEAR AVRG. | 44.7 |
| Capital Invested Productivity | 1.27 |
| Return on Capital Invested (ROCI) | 21.5 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 26.6 |
| Assets Productivity | 0.60 |
| Return on Assets (ROA) | 14.4 |
| Return on Assets (ROA) - 5YEAR AVRG. | 19.6 |
| Gross Profit Margin | 76.1 |
| Gross Profit Margin - 5YEAR AVRG. | 72.3 |
| EBITDA Margin - LTM | 22.2 |
| EBIT Margin - LTM | 18.7 |
| Pre-Tax Profit Margin | 21.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 21.1 |
| Effective Tax Rate | 29.8 |
| Effective Tax Rate - 5YEAR AVRG. | 30.6 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 265 |
| Revenue per Employee | 313,620 |
| Net Income per Employee | 53,290 |
| Average Collection Period | 79 |
| Receivables Turnover | 5.1 |
| Day's Inventory Turnover Ratio | 186 |
| Inventory Turnover | 1.9 |
| Inventory/Sales | 13.4 |
| Accounts Payble/Sales | 11.58 |
| Assets/Revenue | 1.67 |
| Net Working Capital Turnover | 2.17 |
| Fixed Assets Turnover | 2.48 |
| Total Assets Turnover | 0.6 |
| Revenue per $ Cash | 4.68 |
| Revenue per $ Plant | 6.41 |
| Revenue per $ Common Equity | 2.61 |
| Revenue per $ Capital Invested | 1.27 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 40.2 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 37.9 |
| Research & Devlopment (R&D) as % of Revenue | 12.1 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 12.1 |
|
|  
|
| |
 |  |